Literature DB >> 12435814

Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels.

Teresa González1, Ricardo Navarro-Polanco, Cristina Arias, Ricardo Caballero, Ignacio Moreno, Eva Delpón, Juan Tamargo, Michael M Tamkun, Carmen Valenzuela.   

Abstract

The assembly of voltage-gated potassium (Kv) channels with beta subunits modifies the electrophysiological characteristics of the alpha subunits. Kvbeta1.3 subunits shift the midpoint of the activation curve toward more negative voltages and slow the deactivation process. In addition, the Kvbeta1.3 subunit converts hKv1.5 from a delayed rectifier with a modest degree of slow inactivation to a channel with both fast and slow components of inactivation. In the present study, we have analyzed the effects of bupivacaine and a permanently charged analog [R(+)-N-methyl-bupivacaine (RB(+)1C)] on Kvalpha1.5 and Kvalpha1.5+Kvbeta1.3 channels expressed in human embryonic kidney 293 cells using the whole-cell configuration of the patch-clamp technique. Block induced by RB(+)1C binding to its external receptor site was not modified by the presence of this beta subunit. However, hKvalpha1.5+Kvbeta1.3 channels were ~4-fold less sensitive to bupivacaine than hKv1.5 channels in the absence of beta subunits (IC(50) = 47.5 +/- 5.1 versus 13.1 +/- 0.8 microM, respectively, p < 0.01). Quinidine was also less potent to block Kvalpha1.5+Kvbeta1.3 channels than Kvalpha1.5 channels (IC(50) = 49.6 microM versus 6.2 microM, respectively). These results suggest that the Kvbeta1.3 subunit does not modify the affinity of the charged bupivacaine for its external receptor site but markedly reduces the affinity of bupivacaine and quinidine for their internal receptor site in hKv1.5 channels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435814     DOI: 10.1124/mol.62.6.1456

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

Review 1.  Modification of K+ channel-drug interactions by ancillary subunits.

Authors:  Glenna C L Bett; Randall L Rasmusson
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

2.  Structural determinants of Kvbeta1.3-induced channel inactivation: a hairpin modulated by PIP2.

Authors:  Niels Decher; Teresa Gonzalez; Anne Kathrin Streit; Frank B Sachse; Vijay Renigunta; Malle Soom; Stefan H Heinemann; Jürgen Daut; Michael C Sanguinetti
Journal:  EMBO J       Date:  2008-11-06       Impact factor: 11.598

3.  Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel.

Authors:  Jia-Yu Bai; Wei-Guang Ding; Akiko Kojima; Tomoyoshi Seto; Hiroshi Matsuura
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  Regulation of human cardiac Kv1.5 channels by extracellular acidification.

Authors:  Shuang Wang; Wei-Guang Ding; Jia-Yu Bai; Futoshi Toyoda; Min-Jie Wei; Hiroshi Matsuura
Journal:  Pflugers Arch       Date:  2016-10-28       Impact factor: 3.657

5.  Protein kinase C (PKC) activity regulates functional effects of Kvβ1.3 subunit on KV1.5 channels: identification of a cardiac Kv1.5 channelosome.

Authors:  Miren David; Álvaro Macías; Cristina Moreno; Ángela Prieto; Ramón Martínez-Mármol; Rubén Vicente; Teresa González; Antonio Felipe; Michael M Tamkun; Carmen Valenzuela
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

Review 6.  Ion channel trafficking: a new therapeutic horizon for atrial fibrillation.

Authors:  Sarah M Schumacher; Jeffrey R Martens
Journal:  Heart Rhythm       Date:  2010-02-13       Impact factor: 6.343

7.  Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block.

Authors:  R V Frolov; V E Bondarenko; S Singh
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

8.  TRESK-like potassium channels in leukemic T cells.

Authors:  Igor I Pottosin; Edgar Bonales-Alatorre; Georgina Valencia-Cruz; Maria Luisa Mendoza-Magaña; Oxana R Dobrovinskaya
Journal:  Pflugers Arch       Date:  2008-05-28       Impact factor: 3.657

9.  PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.

Authors:  A Macías; A de la Cruz; A Prieto; D A Peraza; M M Tamkun; T González; C Valenzuela
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

10.  miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.

Authors:  Gema Mondejar-Parreño; María Callejo; Bianca Barreira; Daniel Morales-Cano; Sergio Esquivel-Ruiz; Laura Moreno; Angel Cogolludo; Francisco Perez-Vizcaino
Journal:  J Physiol       Date:  2018-06-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.